Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Nov;61(11):2452-2460.
doi: 10.1111/epi.16708. Epub 2020 Oct 14.

Persistent treatment resistance in genetic generalized epilepsy: A long-term outcome study in a tertiary epilepsy center

Emanuele Cerulli Irelli  1 , Alessandra Morano  1 , Francesca A Barone  1 , Giacomo Fisco  1 , Martina Fanella  1 , Biagio Orlando  1 , Jinane Fattouch  1 , Mario Manfredi  1 , Anna Teresa Giallonardo  1 , Carlo Di Bonaventura  1
Affiliations
Observational Study

Persistent treatment resistance in genetic generalized epilepsy: A long-term outcome study in a tertiary epilepsy center

Emanuele Cerulli Irelli et al. Epilepsia. 2020 Nov.

Abstract

Objective: To assess prognostic patterns and investigate clinical and electroencephalography (EEG) variables associated with persistent treatment resistance in a population of genetic generalized epilepsy (GGE) patients with a long-term follow-up.

Methods: Data from GGE patients followed from 1975 to 2019 were reviewed retrospectively. Subjects with a follow-up >10 years, starting from epilepsy diagnosis, were included. Persistent treatment resistance was defined as the absence of any period of remission ≥1 year despite treatment with two appropriate and adequate antiepileptic drugs (AEDs).

Results: One hundred ninety-nine patients were included. The median age was 39.5 years (interquartile range [IQR] 30-49) and the median follow-up was 27 years (IQR 18-35). The most common syndrome was juvenile myoclonic epilepsy (JME), diagnosed in 44.2% of patients. During follow-up, 163 subjects (81.9%) experienced 3-year remission from any seizure type, whereas 5- and 10-year remission occurred in 141 (70.8%) and 92 (46.2%) cases, respectively. The most common prognostic pattern was a relapsing-remitting course, observed in 80 patients (40.2%), whereas 29 (14.6%) displayed persistent treatment resistance. According to multivariable logistic regression analysis, febrile seizures (FS), specific EEG patterns (namely generalized paroxysmal fast activity, GPFA) and valproate (VPA) resistance were the only variables significantly associated with persistent treatment resistance. JME was the only epilepsy syndrome statistically associated with persistent treatment resistance in univariable logistic regression analysis.

Significance: Persistent treatment resistance was observed in almost 15% of GGE patients followed in a tertiary epilepsy center. A worse outcome was associated with specific clinical variables (JME, FS) and EEG patterns (GPFA).

Keywords: generalized paroxysmal fast activity; genetic generalized epilepsy; idiopathic generalized epilepsy; prognostic factors; treatment resistance.

PubMed Disclaimer

References

REFERENCES

    1. Mullen SA, Berkovic SF. Genetic generalized epilepsies. Epilepsia. 2018;59:1148–53.
    1. Jallon P, Latour P. Epidemiology of idiopathic generalized epilepsies. Epilepsia. 2005;46:10–4.
    1. Semah F, Picot M‐C, Adam C, Broglin D, Arzimanoglou A, Bazin B, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 1998;51:1256–62.
    1. Mohanraj R, Brodie MJ. Outcomes of newly diagnosed idiopathic generalized epilepsy syndromes in a non‐pediatric setting. Acta Neurol Scand. 2007;115:204–8.
    1. Berg AT, Shinnar S, Levy SR, Testa FM, Smith‐Rapaport S, Beckerman B, et al. Two‐year remission and subsequent relapse in children with newly diagnosed epilepsy. Epilepsia. 2001;42:553–62.

Publication types

MeSH terms

LinkOut - more resources